share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Director Belldegrun Arie

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Director Belldegrun Arie

Ginkgo Bioworks | 4：持股變動聲明-董事 Belldegrun Arie
美股sec公告 ·  06/15 04:32
牛牛AI助理已提取核心訊息
On June 12, 2024, Arie Belldegrun, associated with Ginkgo Bioworks Holdings, Inc. [DNA], executed a significant transaction involving the company's Class A Common Stock. Belldegrun acquired 105,263 shares through the exercise or conversion of derivative securities, as per the latest SEC filing. Following this transaction, Belldegrun directly holds a total of 194,925 shares of Ginkgo Bioworks. Additionally, an indirect ownership through Bellco Legacy LLC accounts for 500,000 shares. The transaction reflects a notable change in Belldegrun's stake in the company, potentially signaling confidence in Ginkgo Bioworks' future prospects.
On June 12, 2024, Arie Belldegrun, associated with Ginkgo Bioworks Holdings, Inc. [DNA], executed a significant transaction involving the company's Class A Common Stock. Belldegrun acquired 105,263 shares through the exercise or conversion of derivative securities, as per the latest SEC filing. Following this transaction, Belldegrun directly holds a total of 194,925 shares of Ginkgo Bioworks. Additionally, an indirect ownership through Bellco Legacy LLC accounts for 500,000 shares. The transaction reflects a notable change in Belldegrun's stake in the company, potentially signaling confidence in Ginkgo Bioworks' future prospects.
2024年6月12日，與Ginkgo Bioworks Holdings, Inc. [DNA]有關的Arie Belldegrun根據最新的SEC文件進行了一筆重要交易，涉及公司的A類普通股。Belldegrun通過行權或轉換衍生證券獲得了105263股，此次交易後，Belldegrun直接持有Ginkgo Bioworks的總股數爲194925股。此外，通過Bellco Legacy LLC間接擁有500000股。此項交易反映了Belldegrun持股在該公司的明顯變化，有可能顯示對Ginkgo Bioworks未來前景的信懇智能。
2024年6月12日，與Ginkgo Bioworks Holdings, Inc. [DNA]有關的Arie Belldegrun根據最新的SEC文件進行了一筆重要交易，涉及公司的A類普通股。Belldegrun通過行權或轉換衍生證券獲得了105263股，此次交易後，Belldegrun直接持有Ginkgo Bioworks的總股數爲194925股。此外，通過Bellco Legacy LLC間接擁有500000股。此項交易反映了Belldegrun持股在該公司的明顯變化，有可能顯示對Ginkgo Bioworks未來前景的信懇智能。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。